Home » Topics » Regulatory » Patents

Patents
RSS

GSK scientists describe new AMPA receptor agonists in recent patent

Jan. 8, 2009

ChemoCentryx divulges new chemokine CCR1 receptor antagonists for immune disorders

Jan. 8, 2009

New angiotensin II AT1 receptor antagonists developed by Eldrug researchers

Jan. 7, 2009

Novel mutilin derivatives with antibacterial activity reported in recent Kyorin patent

Jan. 7, 2009

Mpex Pharmaceuticals patent discloses novel bacterial efflux pump inhibitors

Jan. 7, 2009

New mgluR2 ligands/5-HT2A antagonists described in Abbott patent

Jan. 5, 2009

New chymase inhibitors for cardiovascular diseases patented at Boehringer Ingelheim

Jan. 5, 2009

Novel matrix metalloproteinase inhibitors from Array BioPharma

Jan. 5, 2009

Dr. Reddy's patents novel antibacterial agents

Dec. 31, 2008

TorreyPines describes new agents for Alzheimer's disease in recent patent

Dec. 31, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...